IL2 and diabetes mellitus: Furthermore, administration of a relatively “lower” dose of IL-2 (complexed with anti-IL-2) promotes survival of Tregs within islets and retards the development of diabetes in NOD mice [38] and prevents autoimmunity in IL-2−/−/Bim−/− double KO mice [39].